UNSPSC 51173224: Danthron/docusate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA209. This VA Drug Class (GA209) classifies this compound as belonging to the group LAXATIVES, OTHER.

UNSPSC 51173224 Danthron/docusate is a Commodity code that, based on recent state and local solicitations, encompasses drug-testing services and related clinical laboratory work rather than the pharmaceutical ingredient its name suggests. State and local governments procure specimen collection, immunoassay screening, confirmatory testing via LC/MS/MS or GC/MS, and ancillary testing methodologies (oral fluid, hair) under this code. Issuing bodies include county community supervision and corrections departments operating offender drug-testing programs. The work requires SAMHSA, state DPS, or CAP laboratory certification and includes both the operational staffing of collection sites and the analytical testing itself, often bundled into a single service contract with per-test pricing models that accommodate volume-based demand and cost-containment provisions.

Collin County Community Supervision and Corrections Department solicited offender specimen collection and drug testing services via RFP 2026-327, posted September 25, 2026, with a proposal due date of July 23, 2026 at 2:00 p.m. The contract covers operation of two collection sites in Plano and McKinney, an Interactive Voice Response notification system, and laboratory testing of approximately 25,031 tests annually across five-panel screens, six-panel screens, and confirmatory work. The estimated contract value is $600,000 over an initial two-year term with three optional one-year renewals, with pricing submitted on a per-test basis and subject to price-redetermination limits tied to medical Consumer Price Index increases not exceeding 3.0 percent annually. Evaluation weights compliance review, vendor understanding (30 points), firm qualifications (25 points), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 points. The anticipated award date is August 10, 2026, with funding from the Texas Department of Criminal Justice–Community Justice Assistance Division.